Bahman Guyuron — FDA Facility Profile

FEI 3013298192

Bahman Guyuron is an FDA-inspected facility (FEI 3013298192) located in Lyndhurst, OH, US. RegDataLab tracks 1 FDA inspection at this facility.

Reviewing Bahman Guyuron as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Bahman Guyuron yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Jun 21, 2017: Voluntary Action Indicated (VAI)
Inspections on record
1 (1 VAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jun 21, 2017Voluntary Action Indicated (VAI)Consent form not approved/signed/dated (21 CFR 50.27(a))
Unanticipated problems (21 CFR 312.66)
Accountability records (21 CFR 312.62(a))
Case history records- inadequate or inadequate (21 CFR 312.62(b))
and 1 more

Facility details

Company
Bahman Guyuron
Location
Lyndhurst, OH (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.